Ultimovacs ASA
Climate Impact & Sustainability Data (2022, 2023)
Reporting Period: 2022
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Responsible Governance
- Patient Safety
- People & Planet
- Social Commitment
- Business Ethics
- Environmental Impact
- Quality Assurance and Risk Assessment
- Transparency
Environmental Achievements
- Minimal greenhouse gas emissions due to small company size and Norway's renewable energy system. Staff prioritize virtual meetings to reduce travel emissions.
Social Achievements
- Zero employee turnover in 2022.
- Commitment to a safe, secure, and positive work environment free of discrimination.
- Competitive employee benefits package.
- Active participation in strengthening collaboration and knowledge sharing within the Oslo Cancer Cluster and Life Science Cluster.
Governance Achievements
- Strong commitment to corporate governance to decrease risk and utilize resources sustainably.
- Adherence to the Norwegian Code of Practice for Corporate Governance.
- ESG report reviewed, discussed, and approved by the Board of Directors.
- Zero incidents of bribery, corruption, or whistleblowing in 2022.
- Received an ESG Risk Score of 19.5 from Sustainalytics (low risk).
Climate Goals & Targets
Long-term Goals:
- Ensure that all ESG-related information is easily accessible for third-party assessment.
Medium-term Goals:
- Assess risk regarding violations of basic human rights and decent working conditions.
Short-term Goals:
- Map suppliers and collaboration business partners' adherence to ESG principles and ethical standards.
Environmental Challenges
- Indirect impact and potential for unintentional ripple effects from work conducted internationally.
- Assessing and managing ESG risks within the supply chain.
Mitigation Strategies
- Conscious association with companies sharing ethical values and professional standards.
- Initiated mapping of suppliers and collaboration partners' adherence to ESG principles and ethical standards.
- Initiated risk assessment regarding human rights and working conditions in the business, supply chains, and other business relationships.
Supply Chain Management
Supplier Audits: 58 critical suppliers screened for ESG policies
Responsible Procurement
- Comprehensive procurement process and structured assessment of critical suppliers to ensure compliance with laws, regulations, and guidelines.
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: UN Global Compact
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- SDG 3: Ensure healthy lives and promote well-being for all at all ages
Ultimovacs' mission is to extend and improve the life of patients by directing the immune system against the core of cancer.
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:2 tonnes GHG
Scope 1 Emissions:0
Scope 2 Emissions:1.8 tonnes
Water Consumption:52 m3
Waste Generated:0.9 tonnes
ESG Focus Areas
- Safety
- Environmental impact
- Diversity
- Business ethics
- Human Rights
Environmental Achievements
- Reduced GHG emissions to 2 tonnes
- Reduced waste to 0.9 tonnes
- Reduced water consumption to 52 m3
Social Achievements
- Zero staff turnover
- Zero whistleblower incidents
- No safety incidents leading to market actions or reporting to health authorities
- More than 300 patients treated with UV1 with no severe safety concerns
Governance Achievements
- Zero complaints or legal proceedings associated with breach of Code of Conduct
- Compliance with GxP regulations (GLP, GMP, GDP, GCP, GVP)
- Implementation of actions in line with the Norwegian Transparency Act (Åpenhetsloven) including accountability in the Board of Directors, guidelines integrated into internal processes, system for handling information obligations, supply chain mapping, and risk analysis of supply chains
Climate Goals & Targets
Environmental Challenges
- Indirect impact and potential for unintentional ripple effects from work
- Business travel, employee commuting, and emissions created by the company’s value chain have not been quantified
Mitigation Strategies
- Collaboration with reputable R&D and manufacturing partners, suppliers, and collaborators located in Europe and the US sharing ethical values and professional standards
- Commitment to continuous improvement in taking wider responsibility for both planet and people
Supply Chain Management
Responsible Procurement
- Comprehensive procurement process and structured assessment of critical suppliers
- Compliance with company’s Code of Conduct, including human rights
Climate-Related Risks & Opportunities
UN Sustainable Development Goals
- Goal 3
Focus on extending and improving patient lives